Sofinnova Ventures
Venture capital
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
14Deep-tech portfolio10 active
4Portfolio exitsAcquired or listed
2Raises, 12 monthsLatest: Mediar Therapeutics
20Co-investorsShare a portfolio company
Portfolio · 14 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Mediar Therapeutics | Biotech | Active | Dec 23, 2025 | $74.6M |
| Aeovian Pharmaceuticals | Biotech | Active | Dec 22, 2025 | $125.0M |
| Star Therapeutics | Biotech | Active | Oct 6, 2025 | $125.0M |
| Avenzo Therapeutics | Biotech | Active | Sep 5, 2025 | $78.7M |
| Marea Therapeutics | Biotech | Active | Jun 24, 2024 | $65.4M |
| ARTBIO | Biotech | Active | — | — |
| Expedition Therapeutics | Biotech | Active | — | — |
| Haya Therapeutics | Biotech | Active | — | — |
| OnCusp Therapeutics | Biotech | Active | — | — |
| Rapport Therapeutics | Biotech | Active | — | — |
| Capstan Therapeutics | Biotech | Acquired | Mar 20, 2024 | $227.0M |
| Kiniksa Pharmaceuticals | Biotech | Public | Nov 23, 2020 | $5.9M |
| Inozyme Pharma | Biotech | Acquired | Jun 8, 2020 | $10.7M |
| Aiolos Bio | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#33
Portfolio exits#49
Raises, 12 months#12
Co-investors#105
Co-investors
- Alexandria Venture InvestmentsVenture capital3 shared
- Third Rock VenturesVenture capital3 shared
- 5AM VenturesVenture capital1 shared
- Aisling CapitalVenture capital1 shared
- ARCH VentureVenture capital1 shared
- Biotechnology Value FundVenture capital1 shared
- ForbionVenture capital1 shared
- F-Prime CapitalVenture capital1 shared
- Ikarian CapitalVenture capital1 shared
- Logos CapitalVenture capital1 shared
Sectors
- Biotech14
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.